aTyr Pharma, Inc. (ATYR)
0.2783
-0.01
(-1.80%)
USD |
NASDAQ |
Oct 07, 16:00
0.2823
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma Market Cap : 27.30M for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 27.30M |
| October 06, 2026 | 27.80M |
| October 05, 2026 | 28.45M |
| October 02, 2026 | 28.17M |
| October 01, 2026 | 28.85M |
| September 30, 2026 | 29.72M |
| September 29, 2026 | 30.18M |
| September 28, 2026 | 29.20M |
| September 25, 2026 | 29.92M |
| September 24, 2026 | 33.11M |
| September 23, 2026 | 36.80M |
| September 22, 2026 | 34.96M |
| September 21, 2026 | 36.57M |
| September 18, 2026 | 35.61M |
| September 17, 2026 | 36.93M |
| September 16, 2026 | 37.68M |
| September 15, 2026 | 38.18M |
| September 14, 2026 | 38.12M |
| September 11, 2026 | 42.16M |
| September 10, 2026 | 42.36M |
| September 09, 2026 | 44.67M |
| September 08, 2026 | 47.16M |
| September 04, 2026 | 48.78M |
| September 03, 2026 | 49.39M |
| September 02, 2026 | 48.36M |
| Date | Value |
|---|---|
| September 01, 2026 | 46.74M |
| August 31, 2026 | 52.15M |
| August 28, 2026 | 52.97M |
| August 27, 2026 | 54.40M |
| August 26, 2026 | 54.05M |
| August 25, 2026 | 55.91M |
| August 24, 2026 | 51.99M |
| August 21, 2026 | 49.19M |
| August 20, 2026 | 49.34M |
| August 19, 2026 | 52.26M |
| August 18, 2026 | 49.45M |
| August 17, 2026 | 50.90M |
| August 14, 2026 | 54.83M |
| August 13, 2026 | 54.24M |
| August 12, 2026 | 53.00M |
| August 11, 2026 | 52.38M |
| August 10, 2026 | 51.88M |
| August 07, 2026 | 50.16M |
| August 06, 2026 | 49.24M |
| August 05, 2026 | 51.89M |
| August 04, 2026 | 51.89M |
| August 03, 2026 | 48.24M |
| July 31, 2026 | 47.62M |
| July 30, 2026 | 47.06M |
| July 29, 2026 | 47.36M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 30.01B |
| ACADIA Pharmaceuticals, Inc. | 3.382B |
| Savara, Inc. | 1.002B |
| Vericel Corp. | 2.085B |
| Biogen, Inc. | 32.81B |
Market Cap Related Metrics
| PS Ratio | 143.28 |
| Price to Book Value | 0.5595 |
| Price | 0.2783 |
| Earnings Yield | -223.8% |